Book Paid Powai Call Girls Mumbai đ 9930245274 đ Low Budget Full Independent H...
Â
Prom lecture by hale
1. HALE TEKA, M.D,
OB/GYN RESIDENT,
MEKELLE UNIVERSITY
Premature Rupture of Membranes
(PROM)
Hale
Digitally signed by Hale
Date: 2019.09.07
21:15:33 +03'00'
3. Introduction
⢠PROM â definition
â Spontaneous membrane rupture before onset of labor
⢠Prevalence
â It complicates
o Overall â 8 â 10% of pregnancies
o Less than 37 weeks â 1%
o 2x common in blacks (US data)
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 3
4. ⢠Its contribution to preterm birth
â 10% in low risk
â 20% in high risk women
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 4
5. ⢠PROM inherently associated with increased perinatal morbidity
and mortality due to:
1. Brief period of latency leading to preterm birth
2. Increased risk risks for perinatal infection
3. Abruptio placenta
4. Diminished oligohydramnios leading to umblical cord
compression
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 5
6. ⢠At term
â Perinatal morbidity and mortality are not significant
â PROM at term usually lead to a delivery of noninfected and
nonasphyxiated infant
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 6
7. ⢠If PROM occurs before 28 +0 weeks,
âthe woman should be well aware of the complications of continuing the
pregnancy and pregnancy can be continuted with informed decision
â˘If PROM occurs before 37 +0 weeks,
âin the absence of contraindications, management should be directed
towards continuing the pregnancy
⢠If a woman comes with PROM, after 37 +0 weeks
âmanagement should be directed towards delivery
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 7
8. Fetal Membrane Anatomy and Physiology
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 8
9. ⢠Fetus develops within amniotic sac, which is surrounded like a balloon
by the fetal membranes
⢠These membranes consists of amniotic and chorionic membranes
which fuse at the end of first trimester
â Thin amnion â has greater tensile strength
âThick chorion
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 9
14. ⢠Risk factors
âLow socioeconomic status,
â Previous history of PPROM or preterm birth
âAsymptomatic second trimester short cervical length
âUterine overdistension,
âSecond- and third-trimester bleeding,
âLow body mass index (BMI),
âNutritional deficiencies of copper and ascorbic acid,
âAbdominal trauma
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 14
15. ⢠Risk factors contâd
âMaternal cigarette smoking,
âCervical conization or cerclage,
âPulmonary disease in pregnancy,
âConnective tissue disorders (e.g., Ehlers-Danlos syndrome), and
âPreterm labor or symptomatic contractions in the current gestation
â Infenctions
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 15
16. ⢠Infections of urogenital tractn â commonly isolated organisims
include
âNeisseria gonorrhoeae,
âChlamydia
âtrachomatis, and
âTrichomonas vaginalis
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 16
17. ⢠Bacterial vaginosis
â Its role in PROM is not clear
o Does it help for ascention of microbes?
o Is it simply a marker of maternal susceptibility for infection?
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 17
18. ⢠Mechanisim of factors leading to PROM
1. Thrombin â mediated
o increase in Poly ADP â ribose polymerase (PARP) cleavage
o Increase in MMP â 1 , 2 and 9
o Decrease in TIMP â 1, and 3
2. Increase in local cytokines, collagenase and protease activities
3. Increase in intrauterine pressure
4. Contractions and cervical diliation lead to fetal membrane physical strain
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 18
19. ⢠Infection
âascending bacterial colonization and infection are integral to the
pathogenesis of preterm PROM in many cases through
1. Direct rlease of proteases
2. Stimulation of inflammatory responses that results in the elaboration of
cytokines, MMPs, and prostaglandins
â In the absence of clinically suspected intrauterine infection
o25 â 35% choriodecidual contamination in women with PROM
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 19
20. Prediction and prevention of PROM
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 20
21. Prediction
â˘Those with a prior delivery near the limit of viability (23 to 27 weeks) have a
27.1% risk of subsequent PTB
â˘Those with a prior history of PTB due to PROM have
âa 3.3-fold higher risk for PTB due to PROM (13.5% vs. 4.1%) and
âa 13.5-fold higher risk for PPROM before 28 weeksâ gestation (1.8% vs. 0.13%)
in a subsequent pregnancy
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 21
22. ⢠Predictors of developing PPROM in nullipara
â Recent symptomatic uterine contractions
â Working during pregnancy
â Having bacterial vaginosis
â Medical complications (including pulmonary diseases)
âShort cervical length (<25 mm)
â BMI < 19.8 kg/m2
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 22
23. ⢠Predictors of developing PPROM in parous women
â Piror PTB due to preterm labor or PROM
â Positive cervicovaginal fFN
â Short cervical length (<25 mm)
â BMI < 19.8 kg/m2
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 23
24. Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 24
RISK FOR PRETERM BIRTH DUE TO PREMATURE RUPTURE OF THE MEMBRANES
AMONG MULTIPARAS
*Positive fFN, cervicovaginal
fFN screen positive (>50
ng/mL) at 22 to 24 weeksâ
gestation.
â Short cervix, cervix length
<25 mm on transvaginal
ultrasound at 22 to 24
weeksâ
gestation.
25. Prevention
â˘Current evidence supports 17-Îą-hydroxyprogesterone caproate
(17-P) treatment for women with a
âprior PTB due to PROM or
âpreterm labor
⢠Evidence also supports treatment with vaginal progesterone for
asymptomatic women with a short cervical length.
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 25
26. ⢠Use of Vit C and E
â Data about their efficacy is conflicting
â Currently not recommended
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 26
27. Clinical Course after PROM
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 27
28. ⢠Hallmarks of PROM
â Brief period of latency
o Period of latency is the time gap in between PROM and onset
of labor
o It has an inverse relationship with gestational age
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 28
29. ⢠Term
â 50% deliver within 5 hours
â 95% deliver within 28 hours
⢠Before 34 weeks
â 93% deliver within 1 week
â 50 â 60% deliver within one week after excluding mothers who require immediate
termination
â Only <5% can anticipate cessation of fluid leakage
â 86% after amniocentesis will reseal
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 29
31. ⢠Maternal Risks
â Chorioamnionitis
o Most common complication â 13 â 16%
o Risk increases as period of latency increases and decreases
with advancing gestational age
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 31
33. ⢠Fetal complications
â ENOS
â Fetal distres and elevated risks of Cesarean delivery due to
associated
o Umblical cord compression
o Cord prolapse
o Sepsis
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 33
34. ⢠Fetal complications contâd
â fetal death â 1 -2%
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 34
35. ⢠Neonatal complications
â RDS â most common serious newborn complication
â NEC
â IVH
â EONS â 2 fold increase
o Can present as acute congenital pneumonia, sepsis, or meningitis
â Chronic lung disease â if delivery occurs remote from term
â Visual or hearing difficulties
â intellectual disabilities
â developmental and motor delay
â cerebral palsy
â death
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 35
36. ⢠Pulmonary hypoplasia
â PPROM in the second trimester
o results from lack of terminal bronchiole and alveolar development
during the canalicular phase of pulmonary development
oCan be accurately diagnosed with
⢠Radial alveolar count
⢠Lung weight
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 36
37. ⢠Lung hypoplasia contâd
â Clinical diagnosis
oSmall chest circumference with severe respiratory distress
o Persistent pulmonary hypotension
â Imaging Dx
o small, weel â aerated lungs with bell â shaped chest and
elevation of the diaphragm
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 37
38. ⢠Lung hypoplasia contâd
â Why does it occur?
oFluid efflux and tracheobronchial collapse after membrane
rupture?
o Loss of intrinsic factors within the tracheobronchial fluid?
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 38
39. ⢠Lung hypoplasia contâd
â develops in 6% of cases in midtrimester PROM
â Carries a 70% mortality rate
â its incidence inversely correlated with gestational age
â complicates nearly 50% of cases with PROM before 19 weeks
and prolonged latency
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 39
40. ⢠Lung hypoplasia contâd
â 74 â 82% with PROM at 15 â 16%
â Letal pulmonary hypoplasia rarely occurs with PROM after 26 weeksâ gestation ( 0 â
1.4%)
â With lesser degree of this condition, related to poor pulmonary compliance and high
ventilatory pressures
o Pneumothorax
o pneumomediastinum
â Restriction deformities occur in about 1.5% of infants delivered after conservative
management after midtrimester PROM but complicate upto 27% of fetuses with
prolonged oligohydramnios
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 40
43. ⢠Confirmation of PROM
â Sterile speculum exam
oVisualization of amniotic fluid passing from the cervical canal or
o Pooling of fluid in the posterior fornix
oVaginal sidewall or posterior fornix pH of more than 6.0 to 6.5 and
oMicroscopic arborized crystals (âferningâ), owing to the interaction of
amniotic fluid proteins and salts, from dried vaginal secretions
obtained by swabbing the posterior fornix with a sterile swab
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 43
44. ⢠Other purposes of sterile speculum exam
â assess cervical status (effacement and dilitation)
â to visualize if there is cord proplapse following ROM
â to assess for cervisitis
â to take cervical and vaginal samples for culture
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 44
45. ⢠Addional confirmatory findings, visualization in the cervical Os of
â Meconium
â Cord
â Vernix
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 45
46. ⢠False â positive pH results may occur with
â Blood
â semen
â bacterial vaginosis
â alkaline antiseptics
â cervical mucus â can also give a false â positive ferning pattern
o The pattern apears floral
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 46
47. ⢠False negative results
â minimal residual fluid
⢠If equivocal result after initial test
â the patient can be placed in a Trendelenburg position and
reexamined after a few hours
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 47
51. â˘Ultrasound â guided dye amnioinfusion (1 mL of indigo carmine + 9
mL sterile saline)
â Observation for passage of dye onto a perineal pad
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 51
52. ⢠Other purposes of ultrasound
â to check for the residual amniotic fluid
â to assess fetal growth
â to assess for BPP
â to check for congenital anomalies that might have probably
caused polyhydramnios and PROM
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 52
53. ⢠The following cervicovaginal markers has been tested for the diagnosis
of PROM but are not currently in clinical use
â fFN
â alpha fetoprotein
â prolactine
â hCG
â PAMG -1
â IGFBP -1
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 53
55. ⢠Management depends on the gestational age
â Before 28 + 0 weeks
o Termination
o Expectant management if an informed mother wishes to extend the
pregnancy
âBefore 37 + 0 weeks
o Expectant management
â After 37 + 0 weeks
o Terminate
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 55
56. ⢠Indications for immediate delivery
1. Term gestation
2. IUFD
3. abnormal fetal well â being (NRBPP)
4. established labor
5. complicated with abruption and significant bleeding
6. complicated with chorioamnionitis
7. complicated with cord proplase
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 56
57. Management of PROM at Term
⢠Immediate induction Vs waiting for spontaneous onset of labor for women with
TERM PROM
â Immediate induction has many benefits without increasing risks of cesarean
delivery or neonatal infection
o Reduced risks of:
⢠prolonged period of latency (duration of ROM untill delivery)
⢠frequency of chorioamnionitis
⢠postpartum fever
⢠neonatal antibiotic therapy
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 57
58. ⢠Induction using oxytocine Vs prostaglandins
â Using oxytocine was found to be associated with reduced risks
of
o prolonged latency
o chorioamnionitis
o neonatal infection
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 58
59. Management of Preterm PROM ( 32 â 36 weeks + 6 days)
⢠Manage conservatively
⢠Delivery can be contemplated if fetal maturity can be
ascertained either from
â vaginal amniotic fluid pool
o preferred, avoids inadverten fetal injury
â amniocentesis
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 59
60. ⢠Indicators of fetal maturity â that indicates delivery as a preferred
option
â Lamellar body coutn > 50,000
â Phosphatidyl glycerol â if positive
â L/S ratio > 2
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 60
61. â˘If the set â up does not allow for determination of lung maturity or
if the lung maturity tests show no evidence of maturity
â Expectant management untill 37 +0 weeks of gestation
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 61
62. Expectant management â approach
⢠Admit
⢠Bed â rest and pelvic rest
⢠Prevention of intrauterine infection â start antibiotic prophylaxis
⢠Acceleration of efetal maturation â Steroids
⢠follow with PROM chart for complications
⢠determine the anovaginal GBS carriage status done within the last 5 weeks
⢠terminate at 37 + 0 weeks if no complications noted on follow
⢠Otherwise, complications like chorioamnionitis, abnormal BPP or abruption dictate termination
before 37 weeks
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 62
63. ⢠Avoid
â Digital examination â shortens period of latency
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 63
64. ⢠Components of PROM chart
â maternal vitals
o BP, PR, RR, Temp
â fetal vitals
oFHB, BPP
â follow up of the condition
o foul smelling vaginal discharge, fever, abdominal pain and
tenderness, leucocyte count
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 64
65. Corticosteroid Administration
⢠Single course
â Betamethasone 12 mg IM daily (2 doses in 48 hours)
âDexamethasone 6 mg IM BID (4 doses in 48 hours)
⢠Rescue course â not settled yet
â if a single course was taken near the limit of viability and the
woman remains undelivered at 32 weeks and she has a high
chance of delivery within 1 week
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 65
66. ⢠Benefits of steroids
â decreases risks of
o RDS
o IVH
o NEC
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 66
67. Antibiotic Administration
⢠Antibiotic treatment
âSignificantly prolongs latency after membrane rupture
âReduces chorioamnionitis,
âReduces the frequencies of newborn complications that include
oneonatal infection,
othe need for oxygen or surfactant therapy, and
oIVH.
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 67
68. ⢠Regimens
â 48 hours of
o ampicillin 2 gram IV Q 6 hours
o erythromycin 250 mg Q 6 hours
â followed by 5 days course of
o amoxicillin 250 mg Q 8 hours
o enteric â coated erythromycin base 333 mg Q 8 hours
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 68
69. ⢠Amoxacillin â clavulinic acid (Augmentin) use must be avoided
⢠Atudies show its association with NEC.
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 69
70. Management of PROM Remote From Term (23 to 31 Weeks)
⢠Indications for immediate delivery in this group that warrant
expeditious delivery because of the increased potential for fetal
death or infection with prolonged membrane rupture:
â Fetal malpresentation,
âfunic presentation,
âhuman immunodeficiency virus (HIV), and
âprimary herpes simplex virus (HSV)
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 70
71. ⢠if expectant is opted by an informed mother
â Daily NST/BPP
â Continuous monitoring
â Bed â rest
â Pelvic â rest
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 71
72. â˘Consensus has not yet been reached regarding the advantages
of inpatient versus outpatient management for the patient who
elects conservative management after previable PROM.
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 72
73. Magnesium Sulfate for Neuroprotection
⢠recommended for anticipated deliveries before 32 weeksâ
gestation after PROM
⢠Regimen
âbolus of 6 g followed by an infusion of 2 g/hr for 12 hours if
undelivered (or continued for imminent delivery)
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 73
74. Tocolysis and Progesterone
⢠Tocolysis â currently not recommened for women with PPROM
⢠Progesterone â currently not recommended for women with
PPROM
â It is only indicated for women with history of PTB and short cercix
with intact memberane
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 74
75. Cerclage
⢠PROM as a complciation of cerclage placement
â Emergency cerclage â 50%
â Elective cerclage â 25%
⢠Because no well-controlled study has found cerclage retention to improve
newborn outcomes after PROM, early cerclage removal is recommended when
PROM occurs
â˘The risks and benefits of short-term cerclage retention during antenatal
corticosteroid are unknown.
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 75
76. Herpes Simplex Virus
⢠Primary HSV
â Perinatal transmission rate â 34 â 80%
⢠Secondary HSV
â Perinatal transmission rate â 1 â 5%
⢠When neonatal HSV infection occurs, the infant mortality rate is
50% to 60%, and up to 50% of survivors will suffer serious sequelae.
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 76
77. ⢠Existing data supports conservative management of PROM
complicated by recurrent maternal HSV infection when the
likelihood of infant mortality and long-term complications with
early delivery is high.
â˘Prophylactic treatment with antiviral agents (e.g., acyclovir) to
reduce viral shedding and the frequency of recurrences is prudent
under this circumstance
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 77
83. ⢠Complications
â Acute
o Preterm labor
o Abruption
o Cord prolapse
o Chorioamnionitis, sepsis
â Late complciations
o DVT
o Muscle wasting
o HAI
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 83
85. ⢠Lab
â an increase in WBC from the baseline
o This might be artificially elevated if antenatal corticosteroids
have been administered within 5 â 7 days
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 85
86. ⢠Amniocentesis
â Amniotic fluid culture
âamniotic fluid glucose concentration below 16 to 20 mg/dL
âGram stain positive for bacteria
âPresence of WBCs on amniotic fluid
âElevated amniotic fluid interleukin levels
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 86
87. Complications of Prolonged Hospitalization
⢠Psychosocial morbidities
⢠Muscle wasting
⢠DVT
âPreventive measures such as leg exercises, antiembolic
stockings, and/or prophylactic doses of subcutaneous heparin
should be considered
Saturday, September 07, 2019 HALE TEKA, M.D., RESIDENT PHYSICIAN 87
88. REFERENCES
HALE TEKA, M.D., RESIDENT PHYSICIAN 88
1. Gabbe, et al., Obstetrics: Normal and Problem Pregnancies 7ed 2017: Elsevier,
Inc.
2. Robert K. Creasy, et al., CREASY & RESNIK'S MATERNAL-FETAL MEDICINE
Principles and Practice 7ed 2014: Saunders, an imprint of Elsevier Inc.
Saturday, September 07, 2019
89. Saturday, September 07, 2019 Hale Teka, M.D., Resident Physician 89
âNo man should escape our
universities without knowing
how little he knows!â
J. Robert Oppenheimer